Authors: | Murciano-Goroff, Y. R.; Drilon, A.; Stadler, Z. K. |
Article Title: | The NCI-MATCH: A national, collaborative precision oncology trial for diverse tumor histologies |
Abstract: | The NCI-MATCH is a national master protocol trial, published in the Journal of Clinical Oncology, in which diverse tumors are sequenced and patients assigned to treatment. The trial demonstrates the feasibility of identifying rare and common actionable genetic alterations and underscores the strength of academic/community partnerships for improving trial access. © 2020 Elsevier Inc. The NCI-MATCH is a national master protocol trial, published in the Journal of Clinical Oncology, in which diverse tumors are sequenced and patients assigned to treatment. The trial demonstrates the feasibility of identifying rare and common actionable genetic alterations and underscores the strength of academic/community partnerships for improving trial access. © 2020 Elsevier Inc. |
Keywords: | immunohistochemistry; adult; unclassified drug; gene mutation; clinical protocol; oncology; cancer research; histology; phosphatidylinositol 3 kinase inhibitor; clinical trial (topic); trastuzumab emtansine; dabrafenib; trametinib; high throughput sequencing; afatinib; nivolumab; azd 4547; gsk 2636771; human; priority journal; article; malignant neoplasm; larotrectinib; capivasertib; adavosertib; gsk 263671 |
Journal Title: | Cancer Cell |
Volume: | 39 |
Issue: | 1 |
ISSN: | 1535-6108 |
Publisher: | Cell Press |
Date Published: | 2021-01-11 |
Start Page: | 22 |
End Page: | 24 |
Language: | English |
DOI: | 10.1016/j.ccell.2020.12.021 |
PUBMED: | 33434511 |
PROVIDER: | scopus |
PMCID: | PMC10640715 |
DOI/URL: | |
Notes: | Article -- Export Date: 1 February 2021 -- Source: Scopus |